The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Here's your Monthly Dose my supplement spotlight on what's trending, what's promising, and what actually holds up under scientific scrutiny. This month: BPC 157. Often called the injury recovery peptide, BPC 157 has The Pharmacology of Longevity: Peptide Edition (Part 1) Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law